JBC INTERFERin siRNA transfection reagent

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M002758200 on May 4, 2000

J. Biol. Chem., Vol. 275, Issue 31, 23847-23851, August 4, 2000
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
275/31/23847    most recent
M002758200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Das, A. K.
Right arrow Articles by Hofmann, S. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Das, A. K.
Right arrow Articles by Hofmann, S. L.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Structural Basis for the Insensitivity of a Serine Enzyme (Palmitoyl-Protein Thioesterase) to Phenylmethylsulfonyl Fluoride*

Amit K. DasDagger , John J. Bellizzi III§**, Sagun Tandel, Edward Biehl, Jon Clardy§, and Sandra L. HofmannDagger ||

From the Dagger  Department of Internal Medicine and the Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, Texas 75390-8593, the § Department of Chemistry and Chemical Biology, Cornell University, Ithaca, New York 14853-1301, and the  Department of Chemistry, Southern Methodist University, Dallas, Texas 75275

Received for publication, March 31, 2000, and in revised form, May 2, 2000

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Palmitoyl-protein thioesterase-1 (PPT1) is a newly described lysosomal enzyme that hydrolyzes long chain fatty acids from lipid-modified cysteine residues in proteins. Deficiency in this enzyme results in a severe neurodegenerative storage disorder, infantile neuronal ceroid lipofuscinosis. Although the primary structure of PPT1 contains a serine lipase consensus sequence, the enzyme is insensitive to commonly used serine-modifying reagents phenylmethylsulfonyl fluoride (PMSF) and diisopropylfluorophosphate. In the current paper, we show that the active site serine in PPT1 is modified by a substrate analog of PMSF, hexadecylsulfonylfluoride (HDSF) in a specific and site-directed manner. The apparent Ki of the inhibition was 125 µM (in the presence of 1.5 mM Triton X-100), and the catalytic rate constant for sulfonylation (k2) was 3.3/min, a value similar to previously described sulfonylation reactions. PPT1 was crystallized after inactivation with HDSF, and the structure of the inactive form was determined to 2.4 Å resolution. The hexadecylsulfonyl was found to modify serine 115 and to snake through a narrow hydrophobic channel that would not accommodate an aromatic sulfonyl fluoride. Therefore, the geometry of the active site accounts for the reactivity of PPT1 with HDSF but not PMSF. These observations suggest a structural explanation as to why certain serine lipases are resistant to modification by commonly used serine-modifying reagents.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Palmitoyl-protein thioesterase-1 (PPT1)1 is a newly described lysosomal hydrolase that removes long chain fatty acids from lipid-modified cysteine residues in fatty acylated proteins (reviewed in Ref. 1). Deficiency of the enzyme leads to a lysosomal storage disease, infantile neuronal ceroid lipofuscinosis, which causes blindness, seizures, and cortical atrophy of the brain (2). Lysosomal inclusion bodies, termed granular osmiophilic deposits, accumulate in all tissues, and resemble lipofuscin deposits that occur during normal aging. In keeping with this important lipid-metabolizing role, PPT1 is one of the most abundant lysosomal enzymes in the brain (3). In contrast to most hydrolytic enzymes (such as proteases, lipases, esterases, and thioesterases), PPT1 is insensitive to the serine-modifying reagents phenylmethylsulfonyl fluoride (PMSF) and diisopropylfluorophosphate (DFP) (4). The insensitivity of PPT1 to these reagents was an important feature of PPT1 because it allowed for the identification of PPT activity in the presence of contaminating lipase and protease activities. We wondered whether there might be structural and/or mechanistic differences between PPT1 and these other lipolytic enzymes that would account for this observation. We have recently determined the three-dimensional crystal structure of PPT1 in the presence and absence of palmitoyl-CoA and shown that palmitate modifies serine 115 of the enzyme (5), confirming that a serine residue is the catalytic nucleophile.

In the current study, we show that although PPT1 is insensitive to inactivation by the serine-reactive reagent PMSF, the enzyme is covalently modified and inactivated by hexadecylsulfonyl fluoride (HDSF) by an active site-directed mechanism. The modified enzyme was crystallized, and the bound inhibitor was identified in the structure. The bound inhibitor defines a narrow, hydrophobic groove leading away from the active site that would not comfortably accommodate an aromatic sulfonyl fluoride. These findings suggest that the active site of PPT1 is readily susceptible to sulfonylation and that the insensitivity of PPT1 to PMSF is due to steric constraints related to the unique structure of the substrate-binding site.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Materials-- Recombinant bovine PPT1 was overexpressed in the Sf9 cell baculovirus system and purified from serum-free SF-900II medium as described previously (6). The purity of the preparations were >90% as assessed by SDS-polyacrylamide gel electrophoresis, and the specific activity of the purified enzyme was 0.7-1.2 µmol of palmitoyl-CoA hydrolyzed per min per mg of purified protein. [3H]Palmitoyl-CoA was synthesized from [3H]palmitic acid as described previously (7). Hexadecylsulfonyl fluoride was prepared as described (8).

Palmitoyl-CoA Hydrolase Assays-- The palmitoyl-CoA hydrolase activity of PPT1 was determined essentially as described (9) by measuring the release of [3H]palmitic acid from [3H]palmitoyl-CoA, which was monitored by liquid scintillation after extraction with Dole's reagent (10). Typically, 30-60 ng of purified recombinant PPT1 was assayed in 100 µl of an assay buffer containing 50 mM HEPES, pH 7.0, 100 mM NaCl, and 2 mM EDTA for 8 min at 37 °C.

Inactivation of PPT1 by Hexadecylsulfonylfluoride-- Inactivation of purified recombinant PPT1 was carried out in buffer containing 50 mM HEPES, pH 7.0, 100 mM NaCl, 2 mM EDTA, and 0.1% Triton X-100 (buffer A) unless otherwise indicated. Triton X-100 (required to maintain solubility of the HDSF) was added to reaction mixtures from a concentrated stock solution (5%). HDSF was added from a concentrated stock solution (100 mM or lower) in Me2SO. Incubations were carried out at 37 °C for varying amounts of time, and the inactivation reactions were stopped by 200-fold or greater dilution into ice-cold enzyme assay buffer. The inactivation was shown not to proceed during the assay under these conditions in control experiments (data not shown).

Kinetics of Inhibition-- The inactivation of PPT1 was assumed to proceed via formation of an intermediate Michaelis complex as described previously (11). The reaction is assumed to follow the course shown in Equation 1.
E+I <LIM><OP><ARROW>⇌</ARROW></OP><LL>k<SUB>−1</SUB></LL><UL>k<SUB>1</SUB></UL></LIM> E-I <LIM><OP><ARROW>→</ARROW></OP><UL>k<SUB>2</SUB></UL></LIM> P (Eq. 1)
where E is enzyme, I is inhibitor, E-I is the intermediate Michaelis complex, and P is the final inactivated product. When experiments are performed under pseudo-first-order conditions (i.e. HDSF well in excess over the enzyme) Equation 1 can be rewritten in the linear form as shown in Equation 2.
1/k<SUB>1</SUB>=1/k<SUB>2</SUB>+K<SUB>i</SUB>/k<SUB>2</SUB>[I] (Eq. 2)
This equation describes the relation between the observed first-order rate constants for inactivation (k1), the rate of sulfonylation in the Michaelis complex (k2), the Michaelis constant Ki, and the concentration of HDSF. Therefore, a double reciprocal plot of the observed first-order rate constants against HDSF concentration yields a straight line with a slope of Ki/k2 and an intercept of 1/k2 on the y axis. To determine the first-order rate constants, reactions were initiated by addition of 20-100 µM HDSF into reaction mixtures containing 1 µM of PPT1. Inactivation was followed by determining the activity remaining at closely spaced time intervals. Activities were expressed as the percentage of initial activity and plotted on a semi-log scale as a function of time. From the semi-log plots, the half-times of inactivation were determined. Observed pseudo-first-order rate constants were calculated using the following equation.
k<SUB>1</SUB>=0.693/t<SUB>1/2</SUB> (Eq. 3)
where t1/2 is the half-time of inactivation determined from semi-log plot. Once a first-order rate constant for each HDSF concentration was calculated, a double reciprocal plot of 1/k1 against 1/[I] was obtained. k2 was calculated from the y intercept, and Ki was determined from the slope as described above.

Crystallization of HDSF-inactivated PPT1-- PPT1 (12 mg/ml in 20 mM HEPES, pH 7.0, 150 mM NaCl, and 0.01% Triton X-100) was inactivated by the addition of 1 mM HDSF. Crystals grew from sitting drop vapor diffusion experiments containing 3 µl of PPT1/HDSF and 2 µl of reservoir solution equilibrated against a 500-µl reservoir containing 55% polypropylene glycol 400 (Fluka) and 100 mM Bis-Tris, pH 6.5. Crystals were harvested from the drops in nylon loops and flash-frozen in liquid nitrogen.

X-ray Data Collection and Structure Determination-- Crystals of HDSF-inactivated PPT1 were analyzed on the A1 beamline at Cornell High Energy Syncotron Source using an ADSC Quantum-4 CCD Detector (12). Diffraction data to 2.4 Å were collected, indexed, and integrated with MOSFLM (13) and scaled and converted to structure factor amplitudes with SCALA and TRUNCATE from the CCP4 package (14). The Rsym is 0.064, and the completeness is 96.5%. Using our previously determined model of uncomplexed PPT1 (5) as a starting point, density for HDSF was clearly visible in difference Fourier maps. The inhibitor was built into the density using O (15), and the complex was refined using simulated annealing, energy minimization, and individual B-factor refinement with the Crystallography and NMR System Software Suite (16). Topology and parameter files for HDSF were created using XPLO2D (17). The working R-factor of the refined model is 0.243, and the Rfree is 0.288, corresponding to 2210 nonhydrogen protein atoms (the entire mature PPT1 polypeptide from residues 28-306), 55 sugar atoms (four N-acetylglucosamine residues), 19 atoms from HDSF, and 40 well defined water molecules (corresponding to peaks greater than 3 sigma  in a sigmaA-weighted Fo - Fc map with hydrogen-bonding partners). The average B-factor is 53.8 Å2.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

In Fig. 1, the chemical structures of the alkylating agents used in this study, HDSF and PMSF, are shown for comparison with a natural substrate of PPT1, a palmitoyl cysteine thioester that normally occurs in the context of a lipid-modified protein or peptide (18). PPT1 prefers acyl chain lengths of 14-18 carbons (6), and no appreciable hydrolysis is observed for chain lengths under eight carbons. Previous work has also shown that there are no major constraints on the nature of the attached "leaving group," because PPT1 readily hydrolyzes other long chain fatty acyl thioesters, such as palmitoyl-CoA (6) and S-palmitoyl thioglucoside (19). The current studies presented below utilized palmitoyl CoA as a substrate because of the availability of facile assays using [3H]palmitoyl-CoA. (However, the kinetic studies presented in Fig. 2 (A and B) were obtained using either [3H]palmitoyl-CoA or [3H]palmitate-labeled Ha-Ras with virtually identical results (data not shown).)


View larger version (6K):
[in this window]
[in a new window]
 
Fig. 1.   Chemical structures of S-palmitoyl-cysteine (in the context of a fatty acylated protein), HDSF, and PMSF.


View larger version (12K):
[in this window]
[in a new window]
 
Fig. 2.   Inhibition of the palmitoyl-CoA hydrolase activity of PPT1 by HDSF but not PMSF. A, time course of inactivation of PPT1 (1 µM) in the presence of 5 mM PMSF (), 5 mM HDSF (black-triangle), or dimethyl sulfoxide (DMSO, solvent, open circle ). B, PPT1 activity as a function of time of incubation with HDSF under pseudo-first-order reaction conditions. Bovine recombinant PPT1 (175 nM) was incubated in the presence of 3 µM HDSF, and aliquots were removed and assayed for remaining activity at the times indicated. The inactivation was linear with respect to the natural logarithm of activity remaining, indicating a bimolecular reaction mechanism. C, stoichiometry of inactivation of PPT1 by HDSF. Purified recombinant PPT1 (10 µM) was incubated with increasing amounts of HDSF for 2 h at 37 °C, and the PPT1 activity remaining was determined. Inactivation was complete at a molar ratio of enzyme to inhibitor of 1:1. D, inactivation of PPT1 by HDSF is inhibited in a competitive manner by increasing concentrations of palmitoyl-CoA. Double reciprocal plots of the pseudo-first-order rate constants of inactivation plotted against increasing HDSF concentrations are shown. Three different palmitoyl CoA concentrations were plotted: 0 µM palmitoyl-CoA (open circle ), 15 µM palmitoyl-CoA (), and 25 µM palmitoyl-CoA (black-triangle).

Fig. 2A shows that incubation of PPT1 with PMSF (5 mM) had no appreciable effect on enzyme activity over that seen with solvent (Me2SO) alone, whereas incubation with HDSF (5 mM), an alkylating agent with a 16-carbon fatty acyl chain, resulted in a very rapid loss of enzyme activity, with 80% inactivation at 1 min and loss of measurable activity at 4 min.

PPT1 has a broad pH optimum with a peak of pH 7.0 when palmitoylated protein or palmitoyl-CoA is used as the substrate. The rate of inactivation of PPT1 by HDSF as a function of pH paralleled this broad pH optimum with the exception that at pH above 7.5, the rate of inactivation became higher but was confounded by an HDSF-independent inactivation that was due to enzyme instability (data not shown). Therefore, the remainder of the studies were conducted at pH 7.0.

As illustrated in Fig. 2B, under pseudo-first-order reaction conditions (i.e. concentration of HDSF at 20-50 times over enzyme concentration), the inactivation of PPT1 by HDSF followed first-order kinetics as shown by the linear relationship between the natural logarithm of remaining activity and reaction time. No loss of activity was observed within the time period of inactivation when HDSF was omitted form the reaction mixture (data not shown). To determine the stoichiometry of inactivation, a precisely determined amount of enzyme was reacted with increasing amounts of HDSF under conditions where the reaction was expected to go to completion (2 h at 37 °C), and the remaining activity was determined (Fig. 2C). 1 mol of HDSF was needed to inactivate 1 mol of enzyme, suggesting that only one PPT1 functional group became modified in the course of inactivation.

In our kinetic study we have assumed that the inactivation of the enzyme by HDSF proceeds through the formation of an intermediate Michaelis complex, as is true for most of the serine hydrolases. To determine the kinetic constants for inactivation, we measured the rate of inactivation of PPT1 at increasing HDSF concentrations under pseudo-first-order conditions. We observed that a plot of the slopes of the natural logarithm of activity remaining became saturated at increasing inhibitor concentration, which is a characteristic of specific (site-directed) irreversible inhibition (20-22). A double reciprocal plot of the observed first-order rate constant of inactivation as a function of HDSF concentration is shown in Fig. 2D (open circles). The y intercept yields the reciprocal of the rate constant k2 of sulfonylation in the Michaelis complex, and the slope (Ki/k2) yields the inhibitor concentration at which the half-maximal rate is observed. From Fig. 2D, we derive a Ki of 125 µM and k2 of 3.3/min for the inactivation of PPT1 by HDSF. The Ki does not represent a true Michaelis dissociation constant in this case, because HDSF is insoluble in aqueous solution and requires Triton X-100 (1.5 mM) for solubilization. In a micellar system, surface concentration in two dimensions is the relevant value, but because it is not possible to measure the surface concentration directly, the concentration is usually expressed as a mole fraction of inhibitor in the detergent micelle, irrespective of the total concentrations of inhibitor and detergent (23, 24). In this case, the Ki reflects a half-maximal rate of inactivation at a mole fraction of HDSF in the Triton X-100 micelle of 0.061, which is somewhat higher than the "affinity constant" of 0.022 measured in a similar experiment that examined the inactivation of Escherichia coli phospholipase A2 by HDSF (8). The k2 compares favorably with the inactivation of chymotrypsin by PMSF (3.1/min) (11) and with the k2 measured for the inactivation of E. coli phospholipase A2 with HDSF (6-17/min) (8). The experiments used to generate the curve in Fig. 2D in the absence of palmitoyl-CoA (open circles) were repeated in the presence of 15 µM palmitoyl-CoA (closed circles) and 25 µM palmitoyl-CoA (closed triangles), which are concentrations that are close to the Km of PPT1 for palmitoyl CoA (40 µM; data not shown). As shown in Fig. 2D, substrate protection from the specific irreversible inhibition of PPT1 by HDSF was demonstrated, as reflected in the unchanged rate constant of sulfonylation (k2) in the presence of substrate, whereas the inhibition constant Ki increased in the presence of substrate (to 235 and 273 µM at 15 and 25 µm palmitoyl-CoA, respectively). The protection of inactivation by substrate confirms an active site-directed mechanism.

HDSF-inactivated PPT1 was crystallized and its three-dimensional crystal structure determined at 2.4 Å resolution (Fig. 3). The binding of HDSF to PPT1 closely mimics the binding of substrate to PPT1 (5). The hexadecyl chain occupies the same hydrophobic groove that palmitate was shown to occupy in our previous structure (Fig. 4A), and serine 115 is covalently modified by the sulfonyl group. There are no significant differences observed between the structure of HDSF-inactivated PPT and the previously determined structures of PPT1 alone and PPT1 bound to palmitate.


View larger version (65K):
[in this window]
[in a new window]
 
Fig. 3.   Crystal structure of PPT1 with bound hexadecylsulfonate. HDSF and the catalytic triad of Ser115, His289, and Asp233 are rendered as ball-and-stick models, and the side chains of the residues lining the substrate-binding pocket are rendered as space-filling models. This figure and Fig. 4 were created with Molscript (33), Bobscript (34), and Raster3D (35).


View larger version (68K):
[in this window]
[in a new window]
 
Fig. 4.   A, HDSF occupies the narrow substrate-binding cleft in PPT1. B, in contrast, the Pseudomonas carboxylesterase active site, occupied here by PMSF, is more open and able to accommodate a wider range of substrates. C, Pseudomonas carboxylesterase residues and PMSF (red) superimposed on the PPT1 active site. The structures were aligned using LSQAB (36) from the CCP4 suite, using the alpha -carbons of the beta  sheet and the catalytic triad residues. Note that the side chain of Met41 occupies the space where PMSF is bound in the carboxylesterase structure, and the presence of Ile235 on the other side of the groove does not provide enough space for PMSF to adopt an alternative conformation.

Superposition of the crystal structure of PMSF-inactivated Pseudomonas carboxylesterase (Protein Data Bank code 1AUR) (Fig. 4B) with HDSF-inactivated PPT1 sheds some light on the molecular details of the specificity of HDSF over PMSF for inactivation of PPT1. The narrow hydrophobic groove leading away from the active site that provides substrate specificity in PPT1 begins with Met41 and Ile235 and is less than 5 Å wide at this point (Fig. 4A). The side chain of Met41 in PPT1 occupies the space where the aromatic ring of PMSF is found in the carboxylesterase structure (Fig. 4C). The side chain of Ile235 would block alternative conformations of PMSF from the active site, and the surrounding environment provides no space to accommodate alternate conformations of the Met41 side chain, which would make room for the PMSF. In contrast, HDSF is able to adopt a conformation that snakes through the channel (Fig. 4A).

    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Enzymes are often classified mechanistically on the basis of their susceptibility to inactivation by class-specific reagents. This classification scheme has served proteolytic enzymes well; for example, serine proteases are nearly universally sensitive to DFP, and classification on the basis of sensitivity to DFP applies to serine proteases such as the digestive proteases and the blood coagulation factors. Lipolytic enzymes have been more problematic, because sensitivity to class-specific reagents is not universal and because detailed reaction mechanisms for many classes of lipolytic enzymes are not well understood. For example, the enzymes lecithin-cholesterol acyltransferase and lipoprotein lipase are readily inactivated by DFP, but the modification occurs not on the catalytic serine but on a second serine that is probably related instead to the substrate-binding site (25). Several additional secreted lipases, most notably bacterial lipases from Staphylococcus hyicus (26) and E. coli (phospholipase A2) (8) and pancreatic lipase (27, 28), are insensitive to DFP and PMSF and yet use serine as the catalytic nucleophile. In the case of the two bacterial lipases, the involvement of a serine residue in the catalytic mechanism was inferred by their sensitivity to the long chain alkylating agent HDSF (8, 29). Pancreatic lipase has been well documented to utilize a classical serine-based triad mechanism based on analysis of its tertiary structure (30). Therefore, it is clear that certain lipases utilize catalytic serine nucleophiles, but for reasons that have not been clear, their active sites are not susceptible to modification by alkylating agents that are commonly used to modify other lipases, esterases, and proteases.

In the current paper, we have described the modification of the active site serine residue of PPT1, a lysosomal lipolytic enzyme, by HDSF, but not the class-specific reagent, PMSF, and provide important direct structural insights into the basis for the selectivity. We found that there is no inherent lack of reactivity of the active site serine for sulfonylation, as evidenced by the similar kinetic constant for sulfonylation (3.3/min) by HDSF as compared with a classical example, sulfonylation of chymotrypsin by PMSF (3.1/min). However, the crystal structure indicates that PPT1 binds the long chain hydrocarbon in a narrow, hydrophobic groove that would not comfortably accommodate an aromatic sulfonyl fluoride.

Interestingly, the converse conclusion (that a more open configuration around the active site would lead to facile inactivation by PMSF and also to a broader substrate specificity) was recently made in relation to another lipolytic enzyme, the carboxylesterase from Pseudomonas fluorescens, a member of the alpha /beta hydrolase superfamily that includes PPT1 (31). As described above, a comparison of these two enzymes was instructive. The salient structural features of both lipases include an alpha /beta fold structure, which consists of a central, predominantly parallel beta  sheet linked by alpha -helical regions and a catalytic serine nucleophile located at the tip of a nucleophilic "elbow." The Pseudomonas carboxylesterase hydrolyzes a broad spectrum of short chain esters, including phenylacetate, p-nitrophenyl esters of short chain fatty acids, and triglycerides such as triacetin and tributyrin but does not hydrolyze substrates with fatty acid chain lengths of over four carbons (32). It is readily inactivated by PMSF, and (as in the case of PPT1 inactivated by HDSF) there are no large structural changes observed upon inhibitor binding. In the structure of the carboxylesterase bound to PMSF, the active site is found in a relatively open configuration that would accommodate a broad variety of small molecules close to the active site but would not (in contrast to PPT1) accept long chain fatty acyl esters because of interfering loops located at a relatively short distance away.

From these observations and others, it has been suggested that the extent of exposure of the active site may be one of the key elements for determining the substrate specificity of the serine esterases (31). Our observations of HDSF bound to PPT1 would support this view, in that the narrow channel leading from the active site serine in PPT1 places severe constraints on the structures of molecules that could be accommodated there, either as substrates or inhibitors.

In summary, we have shown that a lysosomal thioesterase, PPT1, is similar to several other "secreted" lipases in showing insensitivity to class-specific reagents DFP and PMSF. PPT1 is readily inhibited by a sulfonyl fluoride (HDSF) that is structurally more similar to its naturally occurring fatty acyl-containing substrates. The inactivation was shown to be clearly related to modification of a serine residue, which is in a position to act as the catalytic nucleophile in a classical serine-histidine-aspartic acid triad. The relatively closed conformation around the active site of PPT1 accounts for the insensitivity of PPT1 to the classical serine-specific reagent PMSF and provides a structural explanation for the resistance of serine lipases to inactivation by serine-modifying class-specific reagents.

    FOOTNOTES

* This work was supported by National Institutes of Health Grant NS35323 and a research grant from the Robert A. Welch Foundation. The crystallographic work was supported by National Institutes of Health Grant CA59021 (to J. C.), a National Institutes of Health Training Grant in Molecular Physics of Biological Systems (to J. J. B.), and the New York State Sea Grant R/SBP-6 (to J. C.). This work is based in part on research conducted at the Cornell High Energy Synchrotron Source, which is supported by the National Science Foundation under Grant DMR-9311772, using the macromolecular diffraction facility, which is supported by National Institutes of Health Grant RR-01646.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The atomic coordinates and structure factors (code 1EXW) have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ (http://www.rcsb.org).

|| To whom correspondence should be addressed: Hamon Center for Therapeutic Oncology Research, Univ. of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX 75235-8593. Tel.: 214-648-4911; Fax: 214-648-4940; E-mail: hofmann@simmons.swmed.edu.

** Current address: Dept. of Molecular and Cellular Biology, Harvard University, Cambridge, MA 02138.

Published, JBC Papers in Press, May 4, 2000, DOI 10.1074/jbc.M002758200

    ABBREVIATIONS

The abbreviations used are: PPT1, palmitoyl-protein thioesterase-1; HDSF, hexadecylsulfonyl fluoride; PMSF, phenylmethylsulfonyl fluoride; DFP, diisopropylfluorophosphate.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Hofmann, S. L., Lee, L. A., Lu, J. Y., and Verkruyse, L. A. (1997) Neuropediatrics 28, 27-30
2. Vesa, J., Hellsten, E., Verkruyse, L. A., Camp, L. A., Rapola, J., Santavuori, P., Hofmann, S. L., and Peltonen, L. (1995) Nature 376, 584-587
3. Sleat, D. E., Sohar, I., Lackland, H., Majercak, J., and Lobel, P. (1996) J. Biol. Chem. 271, 19191-19198
4. Camp, L. A., and Hofmann, S. L. (1993) J. Biol. Chem. 268, 22566-22574
5. Bellizzi, J. J., Widom, J., Kemp, C., Lu, J.-Y., Das, A. K., Hofmann, S. L., and Clardy, J. (2000) Proc. Natl. Acad. Sci. U. S. A. 97, 4573-4578
6. Camp, L. A., Verkruyse, L. A., Afendis, S. J., Slaughter, C. A., and Hofmann, S. L. (1994) J. Biol. Chem. 269, 23212-23219
7. Duncan, J. A., and Gilman, A. G. (1996) J. Biol. Chem. 271, 23594-23600
8. Horrevoets, A. J. G., Verheij, H. M., and de Hass, G. H. (1991) Eur. J. Biochem. 198, 247-253
9. Mentlein, R., Suttorp, M., and Heymann, E. (1984) Arch. Biochem. Biophys. 228, 230-246
10. Dole, V. P. (1956) J. Clin. Invest. 35, 150-154
11. Gold, A. M., and Fahrney, D. (1964) Biochemistry 3, 783-791
12. Szebenyi, D. M. E., Arvai, A., Ealick, S., Laluppa, J. M., and Nielsen, C. (1997) J. Synchrotron Rad. 4, 128-135
13. Leslie, A. G. W. (1994) MOSFLM , 5.30 Ed. , MRC Laboratory of Molecular Biology, Cambridge, UK
14. Collaborative Computational Project Number 4. (1994) Acta Crystallogr. Sect. D Biol. Crystallogr. 50, 760-763
15. Jones, T., and Kjeldgaard, M. (1997) Methods Enzymol. 277, 173-208
16. Brunger, A. T., Adams, P. D., Clore, G. M., DeLano, W. L., Gros, P., Grosse-Kunstleve, R. W., Jiang, J. S., Kuszewski, J., Nilges, M., Pannu, N. S., Read, R. J., Rice, L. M., Simonson, T., and Warren, G. L. (1998) Acta Crystallogr. Sect. D Biol. Crystallogr. 54, 905-921
17. Kleywegt, G. J., and Jones, T. A. (1997) Methods Enzymol. 277, 208-230
18. Lu, J. Y., Verkruyse, L. A., and Hofmann, S. L. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 10046-10050
19. van Diggelen, O. P., Keulemans, J. L., Winchester, B., Hofman, I. L., Vanhanen, S. L., Santavuori, P., and Voznyi, Y. V. (1999) Mol. Genet. Metab. 66, 240-244
20. Malcolm, A. D., and Radda, G. K. (1970) Eur. J. Biochem. 15, 555-561
21. Brocklehurst, K. (1979) Biochem. J. 181, 775-778
22. Cornish-Bowden, A. (1979) Eur. J. Biochem. 93, 383-385
23. Yu, L., and Dennis, E. A. (1992) Bioorg. Med. Chem. Lett. 2, 1343-1348
24. Hanel, A. M., Schuttel, S., and Gelb, M. H. (1993) Biochemistry 32, 5949-5958
25. Maraganore, J. M., and Heinrikson, R. L. (1986) Trends Biochem. Sci. 11, 497-498
26. van Oort, M. G., Deveer, A. M., Dijkman, R., Tjeenk, M. L., Verheij, H. M., de Haas, G. H., Wenzig, E., and Gotz, F. (1989) Biochemistry 28, 9278-9285
27. Maylie, M. F., Charles, M., and Desnuelle, P. (1972) Biochim. Biophys. Acta 276, 162-175
28. Luthi-Peng, Q., Marki, H. P., and Hadvary, P. (1992) FEBS Lett. 299, 111-115
29. Leuveling Tjeenk, M., Bulsink, Y. B. M., Slotboom, A. J., Verheij, H. M., de Hass, G. H., Demleitner, G., and Gotz, F. (1994) Protein Eng. 7, 579-583
30. Winkler, F. K., D'Arcy, A., and Hunziker, W. (1990) Nature 343, 771-774
31. Kim, K. K., Song, H. K., Shin, D. H., Hwang, K. Y., Choe, S., Yoo, O. J., and Suh, S. W. (1997) Structure 5, 1571-1584
32. Hong, K. H., Jang, W. H., Choi, K. D., and Yoo, O. J. (1991) Agric. Biol. Chem. 55, 2839-2845
33. Kraulis, P. J. (1991) J. Appl. Crystallogr. 24, 946-950
34. Esnouf, R. M. (1997) J. Mol. Graph. Model 15, 132-134
35. Merritt, E. A., and Bacon, D. J. (1997) Methods Enzymol. 277, 505-524
36. Kabsch, W. (1976) Acta Crystallogr. Sect. A 32, 922-923


Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Lipid Res.Home page
A. Das, M. A. Davis, and L. L. Rudel
Identification of putative active site residues of ACAT enzymes
J. Lipid Res., August 1, 2008; 49(8): 1770 - 1781.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
J.-Y. Lu and S. L. Hofmann
Thematic review series: Lipid Posttranslational Modifications. Lysosomal metabolism of lipid-modified proteins
J. Lipid Res., July 1, 2006; 47(7): 1352 - 1357.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
B. Chakravarty, Z. Gu, S. S. Chirala, S. J. Wakil, and F. A. Quiocho
Human fatty acid synthase: Structure and substrate selectivity of the thioesterase domain
PNAS, November 2, 2004; 101(44): 15567 - 15572.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Calero, P. Gupta, M. C. Nonato, S. Tandel, E. R. Biehl, S. L. Hofmann, and J. Clardy
The Crystal Structure of Palmitoyl Protein Thioesterase-2 (PPT2) Reveals the Basis for Divergent Substrate Specificities of the Two Lysosomal Thioesterases, PPT1 and PPT2
J. Biol. Chem., September 26, 2003; 278(39): 37957 - 37964.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
M. Xie, D. Yang, L. Liu, B. Xue, and B. Yan
Human and Rodent Carboxylesterases: Immunorelatedness, Overlapping Substrate Specificity, Differential Sensitivity to Serine Enzyme Inhibitors, and Tumor-Related Expression
Drug Metab. Dispos., May 1, 2002; 30(5): 541 - 547.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Huhtinen, J. O'Byrne, P. J. G. Lindquist, J. A. Contreras, and S. E. H. Alexson
The Peroxisome Proliferator-induced Cytosolic Type I Acyl-CoA Thioesterase (CTE-I) Is a Serine-Histidine-Aspartic Acid alpha /beta Hydrolase
J. Biol. Chem., January 25, 2002; 277(5): 3424 - 3432.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
275/31/23847    most recent
M002758200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Das, A. K.
Right arrow Articles by Hofmann, S. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Das, A. K.
Right arrow Articles by Hofmann, S. L.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.